147 related articles for article (PubMed ID: 22213215)
1. Tumor-specific but not nonspecific cell-free circulating DNA can be used to monitor disease response in lymphoma.
Jones K; Nourse JP; Keane C; Crooks P; Gottlieb D; Ritchie DS; Gill D; Gandhi MK
Am J Hematol; 2012 Mar; 87(3):258-65. PubMed ID: 22213215
[TBL] [Abstract][Full Text] [Related]
2. Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.
Gandhi MK; Lambley E; Burrows J; Dua U; Elliott S; Shaw PJ; Prince HM; Wolf M; Clarke K; Underhill C; Mills T; Mollee P; Gill D; Marlton P; Seymour JF; Khanna R
Clin Cancer Res; 2006 Jan; 12(2):460-4. PubMed ID: 16428487
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma.
Lei KI; Chan LY; Chan WY; Johnson PJ; Lo YM
Clin Cancer Res; 2002 Jan; 8(1):29-34. PubMed ID: 11801537
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type.
Ito Y; Kimura H; Maeda Y; Hashimoto C; Ishida F; Izutsu K; Fukushima N; Isobe Y; Takizawa J; Hasegawa Y; Kobayashi H; Okamura S; Kobayashi H; Yamaguchi M; Suzumiya J; Hyo R; Nakamura S; Kawa K; Oshimi K; Suzuki R
Clin Cancer Res; 2012 Aug; 18(15):4183-90. PubMed ID: 22675173
[TBL] [Abstract][Full Text] [Related]
5. OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation.
Barkholt L; Linde A; Falk KI
Transpl Int; 2005 Jul; 18(7):835-43. PubMed ID: 15948864
[TBL] [Abstract][Full Text] [Related]
6. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients.
Spacek M; Hubacek P; Markova J; Zajac M; Vernerova Z; Kamaradova K; Stuchly J; Kozak T
APMIS; 2011 Jan; 119(1):10-6. PubMed ID: 21143522
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of whole blood Epstein-Barr virus DNA is useful for assessing treatment response in patients with non-Hodgkin's lymphoma.
Jo SA; Hwang SH; Kim SY; Shin HJ; Chung JS; Sol MY; Chang CL; Lee EY
Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e106-13. PubMed ID: 19522857
[TBL] [Abstract][Full Text] [Related]
8. Circulating Epstein-Barr virus DNA in serum of patients with lymphoepithelioma-like carcinoma of the lung: a potential surrogate marker for monitoring disease.
Ngan RK; Yip TT; Cheng WW; Chan JK; Cho WC; Ma VW; Wan KK; Au SK; Law CK; Lau WH
Clin Cancer Res; 2002 Apr; 8(4):986-94. PubMed ID: 11948104
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of cell-free Epstein-Barr virus DNA in the plasma of patients with peripheral T-cell and NK-cell lymphomas and peripheral T-cell proliferative diseases.
Suwiwat S; Pradutkanchana J; Ishida T; Mitarnun W
J Clin Virol; 2007 Dec; 40(4):277-83. PubMed ID: 17996493
[TBL] [Abstract][Full Text] [Related]
10. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R
G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803
[TBL] [Abstract][Full Text] [Related]
11. The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma.
Hohaus S; Santangelo R; Giachelia M; Vannata B; Massini G; Cuccaro A; Martini M; Cesarini V; Cenci T; D'Alo F; Voso MT; Fadda G; Leone G; Larocca LM
Clin Cancer Res; 2011 May; 17(9):2885-92. PubMed ID: 21478335
[TBL] [Abstract][Full Text] [Related]
12. Plasma Epstein-Barr virus DNA screening followed by ¹⁸F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting posttreatment failures of nasopharyngeal carcinoma.
Wang WY; Twu CW; Lin WY; Jiang RS; Liang KL; Chen KW; Wu CT; Shih YT; Lin JC
Cancer; 2011 Oct; 117(19):4452-9. PubMed ID: 21437892
[TBL] [Abstract][Full Text] [Related]
13. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma.
Lin JC; Wang WY; Chen KY; Wei YH; Liang WM; Jan JS; Jiang RS
N Engl J Med; 2004 Jun; 350(24):2461-70. PubMed ID: 15190138
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma.
Shao JY; Zhang Y; Li YH; Gao HY; Feng HX; Wu QL; Cui NJ; Cheng G; Hu B; Hu LF; Ernberg I; Zeng YX
Anticancer Res; 2004; 24(6):4059-66. PubMed ID: 15736452
[TBL] [Abstract][Full Text] [Related]
15. Soluble CD30: a serum marker for Epstein-Barr virus-associated lymphoproliferative diseases.
Haque T; Chaggar T; Schafers J; Atkinson C; McAulay KA; Crawford DH
J Med Virol; 2011 Feb; 83(2):311-6. PubMed ID: 21181928
[TBL] [Abstract][Full Text] [Related]
16. Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection.
Bauer CC; Aberle SW; Popow-Kraupp T; Kapitan M; Hofmann H; Puchhammer-Stöckl E
J Med Virol; 2005 Jan; 75(1):54-8. PubMed ID: 15543583
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of plasma Epstein-Barr virus DNA load as a prognostic marker for nasopharyngeal carcinoma.
Tan EL; Looi LM; Sam CK
Singapore Med J; 2006 Sep; 47(9):803-7. PubMed ID: 16924363
[TBL] [Abstract][Full Text] [Related]
18. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
19. Comparison of serum and whole blood levels of cytomegalovirus and Epstein-Barr virus DNA.
Kullberg-Lindh C; Olofsson S; Brune M; Lindh M
Transpl Infect Dis; 2008 Oct; 10(5):308-15. PubMed ID: 18466193
[TBL] [Abstract][Full Text] [Related]
20. Detection of Epstein-Barr virus DNA in plasma and lymph node biopsy samples of pediatric and adult patients with Hodgkin lymphoma.
Pajand O; Pourakbari B; Mahjob F; Aghamohammadi A; Mamishi N; Mamishi S
Pediatr Hematol Oncol; 2011 Feb; 28(1):10-5. PubMed ID: 21083364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]